• 1
    Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20: 63349.
  • 2
    Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 3149.
  • 3
    Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 76570.
  • 4
    Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006; 12: 297990.
  • 5
    Vogiatzi P, Vindigni C, Roviello F, Renieri A, Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 2007; 211: 28795.
  • 6
    Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 2009; 100: 11517.
  • 7
    Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 46571.
  • 8
    Feng XH, Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 65993.
  • 9
    Ijichi H, Ikenoue T, Kato N et al . Systematic analysis of the TGF-β-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun 2001; 289: 3507.
  • 10
    Markowitz S, Wang J, Myeroff L et al . Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 13368.
  • 11
    Hahn SA, Schutte M, Hoque AT et al . DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 3503.
  • 12
    Xiangming C, Natsugoe S, Takao S et al . Preserved Smad4 expression in the transforming growth factor β signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin Cancer Res 2001; 7: 27782.
  • 13
    Kim JY, Park DY, Kim GH et al . Smad4 expression in gastric adenoma and adenocarcinoma: frequent loss of expression in diffuse type of gastric adenocarcinoma. Histol Histopathol 2005; 20: 5439.
  • 14
    Wang LH, Kim SH, Lee JH et al . Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 2007; 13: 10210.
  • 15
    Xu X, Brodie SG, Yang X et al . Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 2000; 19: 186874.
  • 16
    Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev 2003; 13: 437.
  • 17
    Li Y, Turck CM, Teumer JK, Stavnezer E. Unique sequence, ski, in Sloan–Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 1986; 57: 106572.
  • 18
    Deheuninck J, Luo K. Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res 2009; 19: 4757.
  • 19
    Miyazono K, Maeda S, Imamura T. Smad transcriptional co-activators and co-repressors. In: Ten DijkeP, HeldinCH, eds. Smad Signal Transduction. Netherlands: Springer Netherlands, 2006; 27793.
  • 20
    Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D, Medrano EE. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor β signaling. Cancer Res 2001; 61: 80748.
  • 21
    Fukuchi M, Nakajima M, Fukai Y et al . Increased expression of c-Ski as a co-repressor in transforming growth factor-β signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer 2004; 108: 81824.
  • 22
    Heider TR, Lyman S, Schoonhoven R, Behrns KE. Ski promotes tumor growth through abrogation of transforming growth factor-β signaling in pancreatic cancer. Ann Surg 2007; 246: 618.
  • 23
    Buess M, Terracciano L, Reuter J et al . Amplification of SKI is a prognostic marker in early colorectal cancer. Neoplasia 2004; 6: 20712.
  • 24
    Ritter M, Kattmann D, Teichler S et al . Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia 2006; 20: 43743.
  • 25
    Takahata M, Inoue Y, Tsuda H et al . SKI and MEL1 cooperate to inhibit transforming growth factor-β signal in gastric cancer cells. J Biol Chem 2009; 284: 333444.
  • 26
    Shinagawa T, Nomura T, Colmenares C, Ohira M, Nakagawara A, Ishii S. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene 2001; 20: 81008.
  • 27
    Zhu Q, Krakowski AR, Dunham EE et al . Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 2007; 27: 32439.
  • 28
    Bierie B, Moses HL. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6: 50620.
  • 29
    Komuro A, Yashiro M, Iwata C et al . Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor β signaling. J Natl Cancer Inst 2009; 101: 592604.
  • 30
    Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Br J Cancer 1995; 72: 120010.
  • 31
    Fujihara T, Sawada T, Hirakawa K et al . Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis. Clin Exp Metastasis 1998; 16: 38998.
  • 32
    Yashiro M, Chung YS, Kubo T, Hato F, Sowa M. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts. Br J Cancer 1996; 74: 1096103.
  • 33
    Shibuya K, Shirakawa J, Kameyama T et al . CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 2003; 198: 182939.
  • 34
    Akiyoshi S, Inoue H, Hanai J et al . c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J Biol Chem 1999; 274: 35 26977.
  • 35
    Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003; 3: 80721.
  • 36
    Yagi K, Furuhashi M, Aoki H et al . c-myc is a downstream target of the Smad pathway. J Biol Chem 2002; 277: 85461.
  • 37
    Tran H, Brunet A, Grenier JM et al . DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002; 296: 5304.
  • 38
    Yoo J, Ghiassi M, Jirmanova L et al . Transforming growth factor-β-induced apoptosis is mediated by Smad-dependent expression of GADD45β through p38 activation. J Biol Chem 2003; 278: 43 0017.
  • 39
    Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H. Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993; 53: 18390.
  • 40
    Nakagawa T, Li JH, Garcia G et al . TGF-β induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int 2004; 66: 60513.
  • 41
    Filleur S, Volpert OV, Degeorges A et al . In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes Dev 2001; 15: 137382.
  • 42
    Sakakura C, Mori T, Sakabe T et al . Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24: 299305.
  • 43
    Medrano EE. Repression of TGF-β signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 2003; 22: 31239.
  • 44
    Schwarte-Waldhoff I, Volpert OV, Bouck NP et al . Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 2000; 97: 96249.
  • 45
    Kazerounian S, Yee KO, Lawler J. Thrombospondins: from structure to therapeutics: thrombospondins in cancer. Cell Mol Life Sci 2008; 65: 70012.
  • 46
    Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 284751.
  • 47
    Miyamoto N, Yamamoto H, Taniguchi H et al . Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability. Cancer Lett 2007; 254: 4253.
  • 48
    Hoekstra R, De Vos FY, Eskens FA et al . Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. J Clin Oncol 2005; 23: 518897.